Major supermarket promises to FREEZE formula prices for the rest of the year
Aldi has pledged to freeze the price of its Mamia First Infant Formula for the remainder of 2025.
1
Aldi will continue to charge £6.99 for its own label formula.
That is around £5 less than the average price of formula elsewhere in 2024.
Big name brands like Hipp and Cow & Gate cost around £12 at major retailers such as Boots.
The move comes after data from First Steps Nutrition Trust shows that baby formula prices remain close to historic highs, with the most expensive product on the market now priced at £18.
It was also found that the price of baby milk fell only 50p on average last year, to £11.99, compared to £11.10 in 2021 - four years ago.
The trust said new own-brand infant formulas from Aldi and Lidl have been hitting the market with lower price points.
However, prices of eight of the 12 available infant formulas in shops were still "high and static" between April 2024 and May 2025.
Only the remaining four out of 12 available to customers as of this month are less than £8.50.
The report said that the infant formula market overall remains "dominated by expensive products".
The government is yet to publish a response to the recommendations.
Among the measures suggested by the CMA is that the NHS introduce its own non-brand baby formula in a bid to drive prices down.
It has also proposed existing baby milk products be provided in non-branded containers in hospitals to reduce the impact branded products can have while parents are in a "vulnerable" setting.
The CMA has also put forward that packaging should clearly display nutritional information, while any claims that cannot easily be checked by parents are banned.
It said this would make it easier for parents to pick between brands.
The CMA has made no recommendation on a price cap for baby milk, despite higher prices faced by shoppers in recent years.
It comes after the CMA, the regulator, proposed in February several measures which, if confirmed, could save parents buying baby milk around £300 a year.
Julie Ashfield, chief commercial officer at Aldi UK, said: 'Shoppers should not be paying over the odds for the essentials. As the UK's cheapest supermarket, we're committed to keeping prices low on the products our customers rely on most.
'As formula prices remain at historic highs across the market, we want to reassure parents that at Aldi, there will be no unwelcome surprises at the checkout – we're keeping our Mamia First Infant Formula at just £6.99 for at least the remainder of this year.'
All first infant formula must be nutritionally equivalent, but prices can vary due to factors like branding.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
25 minutes ago
- Daily Mail
Eat to beat bowel cancer - gut doctor reveals SIX hearty snacks to prevent the disease as cases soar in under 50s
A top gut doctor has revealed that one of the simplest ways to cut your risk of bowel cancer could be sitting in your fridge—and it's not just about loading up on fibre. Dr Joseph Salhab says while the digestion-boosting nutrient plays a key role in preventing the disease, it's not the whole story. 'Remember that lowering your risk is not the same as eliminating your risk, but we know people with healthier diet have a lower risk of chronic disease,' he said. One easy way to tip the odds in your favour? Eat a daily portion of yoghurt. The dairy favourite, which contains naturally occurring cancer-fighting bacteria, could reduce bowel cancer risk by as much as 20 per cent, if eat daily, experts have claimed. Dr Salhab, whose Instagram video on the topic has been viewed over 1.4 million times, also recommends adding a handful of nuts to your breakfast. Tree nuts like almonds, hazelnuts and walnuts are packed with fibre, protein and omega-3 fats—all linked to a reduced risk of heart disease, type 2 diabetes, stroke and bowel cancer. But of course, fibre does play an important role too. According to Bowel Cancer UK, a lack of fibre—the indigestible parts of plants that support digestion—is responsible for an alarming 28 per cent of all bowel cancer cases in the UK. Often called roughage, fibre helps maintain a healthy gut by supporting regular bowel movements and reducing the time potential toxins remain in contact with the bowel wall. And Dr Salhab didn't stop there when it comes to easy breakfast swaps that can help ward off disease. According to the gut expert, an apple a day really can keep the doctor away—potentially slashing the risk of colorectal cancer by 47 per cent. Kiwis may be even more powerful. Just one serving provides over 80 per cent of an adult's daily vitamin C needs, and they're rich in antioxidants and phytochemicals that help the body neutralise free radicals—unstable molecules linked to cancer, heart disease and diabetes. Mr Haney Youssef, a colorectal surgeon at The Harborne Hospital in Birmingham, told the Daily Mail earlier this week that fruits high in fibre are crucial for maintaining gut health. He said: 'When beneficial bacteria in our gut ferment fibre, they produce short-chain fatty acids like butyrate. 'These compounds actually nourish the cells lining our bowel and have anti-inflammatory properties that help prevent the cellular changes that can lead to cancer.' And it's not just breakfast foods that offer protection. Snacks like guacamole and salsa can also benefit the digestive tract, according to Dr Salhab. Avocados are rich in phytonutrients with proven cancer-fighting properties and are a good source of healthy fats, which may help guard against colon cancer. Tomatoes, meanwhile, are one of the few major sources of lycopene—a powerful antioxidant shown to reduce the risk of digestive tract cancers, according to the American Institute for Cancer Research. But Dr Salhab stressed that while a healthy diet can lower the risk of chronic diseases such as cancer, 'diet never replaces medical therapy or evaluation.' He urged anyone concerned about changes in their bowel habits to speak to their GP. Common warning signs include persistent changes in bowel movements—such as diarrhoea, constipation, or going more or less often—as well as blood in the stool, abdominal pain, unexplained weight loss, and extreme fatigue. However, bowel cancer can also develop with no symptoms until it has spread, making it far harder to treat. Worryingly, rates are rising among younger adults—defined in cancer terms as those under 50. A recent global study found cases are increasing in 27 of 50 countries. While bowel cancer is strongly linked to obesity, experts say it's increasingly affecting people who are otherwise fit and healthy. Some believe the answer lies in environmental exposures unique to younger generations. Although no single 'smoking gun' has been identified, theories include modern food additives, microplastics, and pollution. Around 44,000 cases of bowel cancer are diagnosed in the UK each year, with around 130,000 in the US. The disease claims nearly 17,000 lives annually in Britain and about 50,000 in America. Overall, just over half of patients survive for at least a decade after diagnosis. According to Cancer Research UK, 54 per cent of bowel cancer cases are preventable.
The Independent
26 minutes ago
- The Independent
NHS ‘invisible waiting list' as three million patients await specialist appointments
Three million patients in England have had no appointment after being referred by their GPs to specialist care, a new analysis has suggested. NHS England figures last month estimated 7.36 million treatments were waiting to be carried out at the end of May, relating to just under 6.23 million patients. The new analysis from MBI Health suggests almost half of those have been left in limbo. Delays in making a first assessment can lead to late diagnosis, worsening symptoms and pressure on emergency services. The Patients Association, which represents patients across the country, said if accurate, t he situation was 'staggering' and meant millions are waiting on an 'invisible waiting list.' The analysis comes after data showed the NHS is making progress in reducing the overall waiting list ahead of Sir Keir Starmer 's promise for 92 per cent of patients to be treated within 18 weeks by March 2029 - a target not met since 2015. MBI's analysis found that around 70 per cent of referral to treatment pathways fall into the category of being 'unseen' since the patient's GP referred them to a specialist. The latest figures show how challenging that target will be, given an estimated one million of the three million unseen patients have already gone more than 18 weeks without receiving any care. The analysis found that ear, nose and throat (ENT), trauma and orthopaedics, gastroenterology, ophthalmology and gynaecology and obstetrics departments were consistently the specialist departments with the greatest number of patients not seen for the first time. Rachel Power, the chief executive of the Patients Association, told the Guardian 'If accurate, three million people are trapped in an invisible waiting list crisis, stuck without basic diagnostic tests of first appointments while their conditions worsen,' 'The scale is staggering, as nearly half of all patients on a waiting list haven't been seen by anyone. That's not a healthcare service; that's a breakdown. 'These aren't just statistics. They're people checking their phones daily for hospital calls that never come, unable to plan their lives while their symptoms deteriorate.' Last month, figures showed 56.1 per cent of those on the list at the end of June this year were of working age (defined as age 19 to 64), up from 55.8 per cent a year ago and 55 per cent in June 2022. At the same time, the proportion of people on the waiting list under the age of 19 has fallen, standing at 10.8 per cent in June this year, down from 11.2 per cent a year earlier and 11.9 per cent in June 2022. The proportion who are over 65 has remained broadly unchanged at around 33.1 per cent. The Department of Health and Social Care (DHSC) said: 'Thanks to this government's record investment, reforms and the hard work of NHS staff, we've cut the waiting list by over 260,000 since July 2024, which also fell for the first time in 17 years in April and May outside the pandemic. On top of this, we have also delivered 4.6m appointments – more than double the 2m we promised. 'This government is delivering the fundamental reform needed to turn our NHS around, and our 10-year health plan will build on this progress, to ensure we meet our target that 92 per cent of patients wait no longer than 18 weeks for treatment by March 2029.'
STV News
26 minutes ago
- STV News
I won't ever sit back and declare ‘job done', says drugs minister
Drugs minister Maree Todd has said she will never 'sit back, relax and say 'job done'' in the fight against drug deaths. Todd was appointed to the role in June following the death of Christina McKelvie earlier this year from secondary breast cancer. Despite the circumstances of the appointment, the former mental health pharmacist said she was 'excited' to move from the social care brief to drugs as the Government continues its push to tackle the level of addiction and death across Scotland. The minister inherits a legacy which has been long-criticised by opponents, with Scotland having the highest drug death rates in Europe – a figure which actually increased between 2022 and 2023 in the latest available confirmed data. Just this week, figures showed the number of suspected drug deaths between March and May of this year increased by 15% compared to the previous 13 weeks. Speaking to the PA news agency, the minister said there is a 'consensus' that 'the work we are doing is the right kind of work', but the Government is responding to a 'changing landscape'. When the Government launched its national mission on drugs under the premiership of Nicola Sturgeon, the focus was largely on opioids such as heroin. But that has shifted, reflecting an increase in the injection of cocaine and the spectre of synthetic opioids known as nitazenes. On the latter, the minister said: 'They are unbelievably potent, super-strong, very tiny amounts can cause fatal overdoses easily.' As it looks to deal with the shifting threat posed by drugs, she stressed the need for the Government to be 'agile'. Todd said: 'We've just had our rapid action drug alerts and response (Radar) statistics released this week and we've seen a rise in deaths, a rise in Naloxone use, a rise in hospital admissions. 'We are seeing some absolutely significant and tangible harm occurring because of the change in the drug supply. 'I suppose the lesson that provides to me is that we need to be agile. 'I don't think we do one thing and this job is done and we fixed the problem that Scotland faces, we have to continually look carefully at what's happening in Scotland, understand the challenges that we're facing, understand the harms that people are experiencing.' She added: 'I don't think I would ever sit back and relax and say 'job done'. 'I think we've seen some significant progress, but each of these deaths is an absolute tragedy – it's a family who's lost a loved one, it's a loss of potential and contribution to our communities.' The way forward, she said , is a job for the whole of Government, saying there is a need for 'primary prevention'. The minister said: 'We need to be thinking, why is it that Scotland faces this challenge and what can we do to shift the likelihood that people growing up in Scotland will turn to drugs and alcohol as they grow older?' Earlier this year, the Thistle Centre opened in the east end of Glasgow, a UK-first safe consumption room giving those struggling with addiction a safe place to inject drugs. Since opening, the facility has supervised 3,008 injecting episodes and dealt with 39 medical emergencies, which could include administering Naloxone or even resuscitation. 'People would definitely have died if they had not been in that unit,' Ms Todd said. 'I think in March, there was a cluster of very profound overdose episodes, I think this is the issue with nitazenes, they act very fast, so people were really unwell really quickly and it takes a lot of Naloxone because of its potency.' In other parts of Scotland without the benefit of a safe consumption room where that specific batch of drug was used, the minister said: 'Where people used it, they did die.' Get all the latest news from around the country Follow STV News Scan the QR code on your mobile device for all the latest news from around the country
